A recent proteomic analysis demonstrated that complement factors were significantly increased in CCA patients (Son et al. 2020) while it was shown that the reduced expression of complement factor H-related 3 is associated with poor prognosis and immune regulation in CCA patients (Wang et al. 2022). Here, CFHR3 is linked to cholangiocarcinoma.